Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy Y Lee

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Heart Rhythm|May 31, 2015
Digoxin therapy and associated clinical outcomes in the MADIT-CRT trialAndy Y Lee, Valentina Kutyifa, Martin H Ruwald, et al.
The American Journal of Cardiology|March 31, 2015
Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT)Andy Y Lee, Arthur J Moss, Martin H Ruwald, et al.
European Journal of Heart Failure|April 30, 2015
Early intervention and long-term outcome with cardiac resynchronization therapy in patients without a history of advanced heart failure symptomsRomana Herscovici, Valentina Kutyifa, Alon Barsheshet, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 14, 2025
Cardiomyopathy in valosin-containing protein multisystem proteinopathy: Evaluation, diagnosis, and managementJoshua M Chan, Candela Romano, Andy Y Lee, et al.
Cardiovascular Diabetology|August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomesAaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
JACC. Cardiooncology|August 16, 2021
Left Ventricular Assist Devices in Patients With Active MalignanciesIlana Schlam, Andy Y Lee, Song Li, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2Peter A McCullough, Aaron Y Kluger, Kristen M Tecson, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic ReviewAaron Y Kluger, Kristen M Tecson, Clay M Barbin, et al.
The American Journal of Cardiology|November 17, 2018
Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac TransplantationFayez S Raza, Andy Y Lee, Aayla K Jamil, et al.
Journal of the American Heart Association|May 19, 2018
Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device ImplantationKristen M Tecson, Brian Lima, Andy Y Lee, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Heart Rhythm|May 31, 2015
Digoxin therapy and associated clinical outcomes in the MADIT-CRT trialAndy Y Lee, Valentina Kutyifa, Martin H Ruwald, et al.
The American Journal of Cardiology|March 31, 2015
Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT)Andy Y Lee, Arthur J Moss, Martin H Ruwald, et al.
European Journal of Heart Failure|April 30, 2015
Early intervention and long-term outcome with cardiac resynchronization therapy in patients without a history of advanced heart failure symptomsRomana Herscovici, Valentina Kutyifa, Alon Barsheshet, et al.
American Heart Journal Plus : Cardiology Research and Practice|November 14, 2025
Cardiomyopathy in valosin-containing protein multisystem proteinopathy: Evaluation, diagnosis, and managementJoshua M Chan, Candela Romano, Andy Y Lee, et al.
Cardiovascular Diabetology|August 7, 2019
Class effects of SGLT2 inhibitors on cardiorenal outcomesAaron Y Kluger, Kristen M Tecson, Andy Y Lee, et al.
JACC. Cardiooncology|August 16, 2021
Left Ventricular Assist Devices in Patients With Active MalignanciesIlana Schlam, Andy Y Lee, Song Li, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2Peter A McCullough, Aaron Y Kluger, Kristen M Tecson, et al.
Reviews in Cardiovascular Medicine|April 30, 2019
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic ReviewAaron Y Kluger, Kristen M Tecson, Clay M Barbin, et al.
The American Journal of Cardiology|November 17, 2018
Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac TransplantationFayez S Raza, Andy Y Lee, Aayla K Jamil, et al.
Journal of the American Heart Association|May 19, 2018
Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device ImplantationKristen M Tecson, Brian Lima, Andy Y Lee, et al.
Pageof 3